Safety and efficacy of peginterferon alfa-2a (40kd) (Pegasys (R)) plus ribavirin (Copegus (R)) in HIV-HCV co-infected patients with cirrhosis/bridging fibrosis: Results of the AIDS Pegasys Ribavirin International Co-Infection Trial (APRICOT)

HEPATOLOGY(2004)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要